XML 31 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated statements of changes in equity - BRL (R$)
R$ in Thousands
Total
Share capital
Equity instrument granted
Capital reserve
Treasury shares
Revaluation reserve on subsidiaries
Legal Reserve
Investments statutory reserve
Accumulated other comprehensive income
Retained earnings
Additional dividends to the minimum mandatory dividends
Shareholders of the Company
Non-controlling interests
 [2]
Beginning balance at Dec. 31, 2021 R$ 10,469,240 R$ 5,171,752 R$ 34,043 R$ 596,481 R$ (488,425) R$ 4,154 R$ 792,533 R$ 4,073,876 R$ (117,493) [1]     R$ 10,066,921 R$ 402,319
Net income for the year 1,840,069                 R$ 1,800,839   1,800,839 39,230
Other comprehensive income:                          
Other comprehensive income 297,670               297,467 [1]     297,467 203
Total comprehensive income for the year 2,137,739               297,467 [1] 1,800,839   2,098,306 39,433
Issuance of shares related to the subscription warrants - indemnification 941     941               941  
Equity instrument granted 20,734   9,944 2,039 8,751             20,734  
Realization of revaluation reserve of subsidiaries           (179)       179      
Dividends prescribed 2,948                 2,948   2,948  
Shareholder transaction - changes of ownership interest (6,567)             (6)   286   280 (6,847)
Gain due to change in ownership interest (2,423)                       (2,423)
Capital increase attributable to non-controlling interests 35,182                       35,182
Dividends attributable to non-controlling interests (1,437)                       (1,437)
Allocation of net income:                          
Legal reserve             90,042     (90,042)      
Investments statutory reserve               1,154,691   (1,154,691)      
Additional minimum mandatory dividend for the year (R$ 0.26 per share) (31,385)                 (31,385)   (31,385)  
Additional dividends (R$ 0.19 per share) (78,130)                 (78,130) R$ 78,130    
Interest on capital attributable to non-controlling interests (450,004)                 (450,004)   (450,004)  
Interim dividends (R$ 0.25 per share) 0                        
Ending balance at Dec. 31, 2022 12,174,968 5,171,752 43,987 599,461 (479,674) 3,975 882,575 5,228,561 179,974 [1]   78,130 11,708,741 466,227
Net income for the year 2,517,753                 2,439,795   2,439,795 77,958
Other comprehensive income:                          
Other comprehensive income (40,370)               (25,866)     (25,866) (14,504)
Total comprehensive income for the year 2,477,383               (25,866) 2,439,795   2,413,929 63,454
Issuance of shares related to the subscription warrants - indemnification 560     560               560  
Equity instrument granted 38,909   31,938 (2,193) 9,164             38,909  
Realization of revaluation reserve of subsidiaries (113)         (173)       60   (113)  
Capital increase with reserves   1,450,000         (882,575) (567,425)          
Loss due to change in ownership interest (45)                       (45)
Dividends prescribed 2,048                 2,048   2,048  
Special reserve for mandatory dividend not distributed to non-controlling shareholders (11,145)                       (11,145)
Shareholder transaction - changes of ownership interest 2             2       2  
Non-controlling interest in acquired subsidiary 24,303                       24,303
Dividends attributable to non-controlling interests (19,463)                       (19,463)
Approval of additional dividends by the Ordinary General Shareholders' Meeting (78,130)                   (78,130) (78,130)  
Allocation of net income:                          
Legal reserve             121,990     (121,990)      
Investments statutory reserve               1,606,431   (1,606,431)      
Additional minimum mandatory dividend for the year (R$ 0.26 per share) (305,653)                 (305,653)   (305,653)  
Additional dividends (R$ 0.19 per share) (134,031)                 (134,031) 134,031    
Interim dividends (R$ 0.25 per share) (273,798)                 (273,798)   (273,798)  
Ending balance at Dec. 31, 2023 14,029,826 6,621,752 75,925 597,828 (470,510) 3,802 121,990 6,267,569 154,108 0 134,031 13,506,495 523,331
Net income for the year 2,525,900                 2,362,740   2,362,740 163,160
Other comprehensive income:                          
Other comprehensive income 69,847               60,104     60,104 9,743
Total comprehensive income for the year 2,595,747               60,104 2,362,740   2,422,844 172,903
Issuance of shares related to the subscription warrants - indemnification 6,452     6,452               6,452  
Equity instrument granted 57,458   32,328 2,069 23,055             57,452 6
Purchase of treasury shares (148,945)       (148,945)             (148,945)  
Realization of revaluation reserve of subsidiaries           (170)       170      
Reserve constitution 5,663     5,699               5,699 (36)
Dividends prescribed 3,369                 3,369   3,369  
Shareholder transaction - changes of ownership interest 843                 534   534 309
Non-controlling interest in acquired subsidiary 112,160                       112,160
Dividends attributable to non-controlling interests (38,357)                       (38,357)
Approval of additional dividends by the Ordinary General Shareholders' Meeting (134,031)                   (134,031) (134,031)  
Allocation of net income:                          
Legal reserve             118,137     (118,137)      
Investments statutory reserve               1,479,404   (1,479,404)      
Additional minimum mandatory dividend for the year (R$ 0.26 per share) (285,180)                 (285,180)   (285,180)  
Additional dividends (R$ 0.19 per share) (208,121)                 (208,121) 208,121    
Interest on capital attributable to non-controlling interests (105,590)                       (105,590)
Interim dividends (R$ 0.25 per share) (275,971)                 (275,971)   (275,971)  
Ending balance at Dec. 31, 2024 R$ 15,823,444 R$ 6,621,752 R$ 108,253 R$ 612,048 R$ (596,400) R$ 3,632 R$ 240,127 R$ 7,746,973 R$ 214,212 R$ 0 R$ 208,121 R$ 15,158,718 R$ 664,726
[1] Considers cumulative translation adjustment from discontinued operations. The accumulated effects were reclassified to income as a result of the sale of Oxiteno.The accompanying notes are an integral part of the financial statements.
[2] Are substantially represented by non-controlling shareholders of Iconic.